Table 4 Treatment and clinical outcome of the ovarian cancer patients
Parameter | N (%) |
|---|---|
Neoadjuvant Therapy | |
Yes | 10(6.9) |
No | 91(62.3) |
Missing data | 45(30.8) |
Adjuvant Therapy | |
Yes | 68(46.6) |
No | 16(11.0) |
Deceased before therapy | 3(2.0) |
Missing or insufficient data | 59(40.4) |
Post-Relapse Therapy | |
Yes | 23(74.2) |
No | 2(6.3) |
Missing or insufficient data | 6(19.5) |
Clinical Outcome | |
Cure | 7(4.8) |
Disease-free | 23(15.7) |
Relapse | 30(20.5) |
Death before relapse | 24(16.4) |
Relapse after cure | 1(0.7) |
Missing or insufficient data | 61(41.8) |
Platinum responsiveness | |
Resistant | 25(17.1) |
Susceptible | 33(22.6) |
No platinum-based therapy | 17(11.6) |
Missing or insufficient data | 71(48.6) |